STOCK TITAN

Opiant Pharmaceuticals to Participate at the Jefferies 2020 Virtual London Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Opiant Pharmaceuticals, a specialty pharmaceutical firm focused on addiction and drug overdose treatments, announced that CEO Dr. Roger Crystal will present at the Jefferies 2020 Virtual London Healthcare Conference on November 19, 2020, at 6:45 pm GMT. Management will also hold virtual one-on-one meetings throughout the conference, occurring from November 17-19, 2020. Investors and the public can access a live audio webcast of the presentation on the Opiant website, with a replay available for 90 days post-event.

Positive
  • None.
Negative
  • None.

SANTA MONICA, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, announced today that its Chief Executive Officer, Dr. Roger Crystal, is scheduled to present its pipeline at the Jefferies 2020 Virtual London Healthcare Conference on Thursday, November 19th, 2020, at 6:45 pm GMT.

Management will be available for virtual one-on-one meetings throughout the conference taking place November 17-19, 2020. Please contact Jefferies sales representatives to participate in their investor conferences and to schedule a virtual one-on-one meeting with our management team. 

Investors, analysts, members of the media and the general public are invited to listen to an audio webcast of the presentation that can be accessed via the investor section of the Opiant website: www.opiant.com. A replay of the webcast will be available for 90 days following the event.

About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information, visit: www.opiant.com.

Investor Relations Contacts:

Ben Atkins
VP of Corporate Communications and Investor Relations
Batkins@opiant.com
(310) 598-5410

FAQ

When is Opiant Pharmaceuticals' presentation at the Jefferies 2020 Virtual London Healthcare Conference?

Opiant Pharmaceuticals' presentation is scheduled for November 19, 2020, at 6:45 pm GMT.

How can I access the Opiant Pharmaceuticals presentation?

The presentation can be accessed via a live audio webcast on the Opiant website.

What dates will the Jefferies 2020 Virtual London Healthcare Conference take place?

The conference will occur from November 17 to November 19, 2020.

Who will represent Opiant Pharmaceuticals at the Jefferies conference?

CEO Dr. Roger Crystal will represent Opiant Pharmaceuticals at the Jefferies conference.

Is there an opportunity for one-on-one meetings with Opiant Pharmaceuticals management during the conference?

Yes, management will be available for virtual one-on-one meetings throughout the conference.

OPNT

NASDAQ:OPNT

OPNT Rankings

OPNT Latest News

OPNT Stock Data

108.80M
4.82M
7.64%
42%
0.78%
Biotechnology
Healthcare
Link
United States
Santa Monica